These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

882 related items for PubMed ID: 20369902

  • 1. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC.
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A, Shafer D.
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [Abstract] [Full Text] [Related]

  • 5. Advances in the use of botulinum neurotoxins in facial esthetics.
    Flynn TC.
    J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL, Wilson AJ, Taglienti AJ, Chang CS, Folsom N, Percec I.
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [Abstract] [Full Text] [Related]

  • 11. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
    Hexsel D, Brum C, do Prado DZ, Soirefmann M, Rotta FT, Dal'Forno T, Rodrigues TC.
    J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW, Pijpe J, Jansma J.
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.